Have a personal or library account? Click to login
Rheumatic Heart Disease is Missing from the Global Health Agenda Cover

Rheumatic Heart Disease is Missing from the Global Health Agenda

Annals of Global Health
Volume 87 (2021): Issue 1
By: Wubishet Belay and  Muktar H. Aliyu  
Open Access
|Nov 2021

References

  1. 1Karthikeyan G, Guilherme L. Acute rheumatic fever. Lancet. 2018; 392(10142): 161–174. DOI: 10.1016/S0140-6736(18)30999-1
    Back to article
  2. 2Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. The Lancet. 2005; 366(9480): 155–168. DOI: 10.1016/S0140-6736(05)66874-2
    Back to article
  3. 3Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database of Systematic Reviews. 2002; (3). DOI: 10.1002/14651858.CD002227
    Back to article
  4. 4Steer AC, Carapetis JR. Prevention and treatment of rheumatic heart disease in the developing world. Nature Reviews Cardiology. 2009; 6(11): 689–698. DOI: 10.1038/nrcardio.2009.162
    Back to article
  5. 5Gordis L. The virtual disappearance of rheumatic fever in the United States: Lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation. 1985; 72(6): 1155–1162. DOI: 10.1161/01.CIR.72.6.1155
    Back to article
  6. 6Beaton A, Aliku T, Okello E, et al. The utility of handheld echocardiography for early diagnosis of rheumatic heart disease. Journal of the American Society of Echocardiography. 2014; 27(1): 42–49. DOI: 10.1016/j.echo.2013.09.013
    Back to article
  7. 7Bennett J, Zhang J, Leung W, et al. Rising ethnic inequalities in acute rheumatic fever and rheumatic heart disease, New Zealand, 2000–2018. Emerging Infectious Diseases Journal – CDC. 2021; 27(1). DOI: 10.3201/eid2701.191791
    Back to article
  8. 8Katzenellenbogen JM, Bond-Smith D, Seth RJ, et al. Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: The case for policy change. Journal of the American Heart Association. 2020; 9(19): e016851. DOI: 10.1161/JAHA.120.016851
    Back to article
  9. 9Macleod CK, Bright P, Steer AC, Kim J, Mabey D, Parks T. Neglecting the neglected: The objective evidence of underfunding in rheumatic heart disease. Trans R Soc Trop Med Hyg. 2019; 113(5): 287–290. DOI: 10.1093/trstmh/trz014
    Back to article
  10. 10Shawar YR, Shiffman J. Generating global priority for addressing rheumatic heart disease: A qualitative policy analysis. Journal of the American Heart Association. 2020; 9(8): e014800. DOI: 10.1161/JAHA.119.014800
    Back to article
  11. 11Dougherty S, Beaton A, Nascimento BR, Zühlke LJ, Khorsandi M, Wilson N. Prevention and control of rheumatic heart disease: Overcoming core challenges in resource-poor environments. Ann Pediatr Cardiol. 2018; 11(1): 68–78. DOI: 10.4103/apc.APC_135_17
    Back to article
  12. 12Watkins DA, Zuhlke LJ, Engel ME, Mayosi BM. Rheumatic fever: Neglected again. Science. 2009; 324(5923): 37. DOI: 10.1126/science.324.5923.37b
    Back to article
  13. 13Engel ME, Haileamlak A, Zühlke L, et al. Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia. Heart. 2015; 101(17): 1389–1394. DOI: 10.1136/heartjnl-2015-307444
    Back to article
  14. 14Beaton A, Okello E, Lwabi P, Mondo C, McCarter R, Sable C. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren. Circulation. 2012; 125(25): 3127–3132. DOI: 10.1161/CIRCULATIONAHA.112.092312
    Back to article
  15. 15Kane A, Mirabel M, Touré K, et al. Echocardiographic screening for rheumatic heart disease: Age matters. Int J Cardiol. 2013; 168(2): 888–891. DOI: 10.1016/j.ijcard.2012.10.090
    Back to article
  16. 16Saxena A, Zühlke L, Wilson N. Echocardiographic screening for rheumatic heart disease: Issues for the cardiology community. Global Heart. 2013; 8(3): 197–202. DOI: 10.1016/j.gheart.2013.08.004
    Back to article
  17. 17Zhang W, Okello E, Nyakoojo W, Lwabi P, Mondo CK. Proportion of patients in the Uganda rheumatic heart disease registry with advanced disease requiring urgent surgical interventions. Afr Health Sci. 2015; 15(4): 1182–1188. DOI: 10.4314/ahs.v15i4.17
    Back to article
  18. 18Grimaldi A, Ammirati E, Vermi AC, et al. Cardiac surgery for patients with heart failure due to structural heart disease in Uganda: Access to surgery and outcomes. Cardiovasc J Afr. 2014; 25(5): 204–211. DOI: 10.5830/CVJA-2014-034
    Back to article
  19. 19Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009; 374(9693): 934–947. DOI: 10.1016/S0140-6736(09)61087-4
    Back to article
  20. 20Zühlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: Recent advances and current priorities. Heart. 2013; 99(21): 1554–1561. DOI: 10.1136/heartjnl-2013-303896
    Back to article
  21. 21James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018; 392(10159): 1789–1858. DOI: 10.1016/S0140-6736(18)32279-7
    Back to article
  22. 22Zühlke L, Karthikeyan G, Engel ME, et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease From 14 low- and middle-income countries: Two-year follow-up of the global rheumatic heart disease registry (the REMEDY Study). Circulation. 2016; 134(19): 1456–1466. DOI: 10.1161/CIRCULATIONAHA.116.024769
    Back to article
  23. 23Sika-Paotonu D, Beaton A, Raghu A, Steer A, Carapetis J. Acute rheumatic fever and rheumatic heart disease. In: Ferretti JJ, Stevens DL, Fischetti VA (eds.), Streptococcus Pyogenes: Basic Biology to Clinical Manifestations. University of Oklahoma Health Sciences Center; 2016. Accessed September 27, 2021. http://www.ncbi.nlm.nih.gov/books/NBK425394/.
    Back to article
  24. 24Kingué S, Ba SA, Balde D, et al. The VALVAFRIC study: A registry of rheumatic heart disease in Western and Central Africa. Archives of Cardiovascular Diseases. 2016; 109(5): 321–329. DOI: 10.1016/j.acvd.2015.12.004
    Back to article
  25. 25Opara CC, Du Y, Kawakatsu Y, et al. Household economic consequences of rheumatic heart disease in Uganda. Frontiers in Cardiovascular Medicine. 2021; 8: 680. DOI: 10.3389/fcvm.2021.636280
    Back to article
  26. 26Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. New England Journal of Medicine. 2017; 377(8): 713–722. DOI: 10.1056/NEJMoa1603693
    Back to article
  27. 27Heenan RC, Parks T, Bärnighausen T, Kado J, Bloom DE, Steer AC. The cost-of-illness due to rheumatic heart disease: National estimates for Fiji. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2020; 114(7): 483–491. DOI: 10.1093/trstmh/trz118
    Back to article
  28. 28Opara CC, Aghassibake N, Watkins DA. Economic consequences of rheumatic heart disease: A scoping review. International Journal of Cardiology. 2021; 323: 235–241. DOI: 10.1016/j.ijcard.2020.09.020
    Back to article
  29. 29Watkins D, Daskalakis A. The economic impact of rheumatic heart disease in developing countries. The Lancet Global Health. 2015; 3: S37. DOI: 10.1016/S2214-109X(15)70156-7
    Back to article
  30. 30Zühlke LJ, Engel ME. The importance of awareness and education in prevention and control of RHD. Global Heart. 2013; 8(3): 235–239. DOI: 10.1016/j.gheart.2013.08.009
    Back to article
  31. 31Nkoke C, Luchuo EB, Jingi AM, Makoge C, Hamadou B, Dzudie A. Rheumatic heart disease awareness in the South West region of Cameroon: A hospital based survey in a Sub-Saharan African setting. PLoS One. 2018; 13(9): e0203864. DOI: 10.1371/journal.pone.0203864
    Back to article
  32. 32Watkins D, Zuhlke L, Engel ME, et al. Seven key actions to eradicate rheumatic heart disease in Africa: The Addis Ababa communiqu. SAMJ South African Medical Journal. 2016; 27(3): 184–187. DOI: 10.5830/CVJA-2015-090
    Back to article
  33. 33Merson MH, O’Malley J, Serwadda D, Apisuk C. The history and challenge of HIV prevention. The Lancet. 2008; 372(9637): 475–488. DOI: 10.1016/S0140-6736(08)60884-3
    Back to article
  34. 34Granich R, Kahn JG, Bennett R, et al. Expanding ART for treatment and prevention of HIV in South Africa: Estimated cost and cost-effectiveness 2011–2050. PLOS ONE. 2012; 7(2): e30216. DOI: 10.1371/journal.pone.0030216
    Back to article
  35. 35Falase B, Sanusi M, Majekodunmi A, Ajose I, Idowu A, Oke D. The cost of open heart surgery in Nigeria. Pan Afr Med J. 2013; 14. DOI: 10.11604/pamj.2013.14.61.2162
    Back to article
  36. 36White A. WHO Resolution on rheumatic heart disease. European Heart Journal. 2018; 39(48): 4233–4233. DOI: 10.1093/eurheartj/ehy764
    Back to article
DOI: https://doi.org/10.5334/aogh.3426 | Journal eISSN: 2214-9996
Journal RSS Feed
Language: English
Published on: Nov 17, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Wubishet Belay, Muktar H. Aliyu, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 87 (2021): Issue 1Next article